{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:42:00Z","timestamp":1793104920659,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Repetitive head injury in contact sports is associated with cognitive, neurobehavioral, and motor impairments and linked to a unique neurodegenerative disorder: chronic traumatic encephalopathy (CTE). As the clinical presentation is variable, risk factors are heterogeneous, and diagnostic biomarkers are not yet established, the diagnostic process of CTE remains a challenge. The general objective of the NEwTON study is to establish a prospective cohort of individuals with high risk for CTE, to phenotype the study population, to identify potential fluid and neuroimaging biomarkers, and to measure clinical progression of the disease. The present paper explains the protocol and design of this case-finding study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>NEwTON is a prospective study that aims to recruit participants at risk for CTE, with features of the traumatic encephalopathy syndrome (exposed participants), and healthy unexposed control individuals. Subjects are invited to participate after diagnostic screening at our memory clinic or recruited by advertisement. Exposed participants receive a comprehensive baseline screening, including neurological examination, neuropsychological tests, questionnaires and brain MRI for anatomical imaging, diffusion tensor imaging (DTI), resting-state functional MRI (rsfMRI), and quantitative susceptibility mapping (QSM). Questionnaires include topics on life-time head injury, subjective cognitive change, and neuropsychiatric symptoms. Optionally, blood and cerebrospinal fluid are obtained for storage in the NEwTON biobank. Patients are informed about our brain donation program in collaboration with the Netherlands Brain Brank. Follow-up takes place annually and includes neuropsychological assessment, questionnaires, and optional blood draw. Testing of control subjects is limited to baseline neuropsychological tests, MRI scan, and also noncompulsory blood draw.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>To date, 27 exposed participants have finished their baseline assessments. First baseline results are expected in 2023.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The NEwTON study will assemble a unique cohort with prospective observational data of male and female individuals with high risk for CTE. This study is expected to be a primary explorative base and designed to share data with international CTE-related cohorts. Sub-studies may be added in the future with this cohort as backbone.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-022-01059-8","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T13:06:47Z","timestamp":1662037607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Rationale and design of the \u201cNEurodegeneration: Traumatic brain injury as Origin of the Neuropathology (NEwTON)\u201d study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathy"],"prefix":"10.1186","volume":"14","author":[{"given":"Suzan","family":"van Amerongen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewi K.","family":"Caton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra J. W.","family":"Pouwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J. M.","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J. M.","family":"Hoozemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande A. L.","family":"Pijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everard G. B.","family":"Vijverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"1059_CR1","first-page":"D1540","volume":"161","author":"J van der Naalt","year":"2017","unstructured":"van der Naalt J, Draijer WL, van Bennekom CAM. Identifying mild traumatic brain injury: clinical signs and consequences. Ned Tijdschr Geneeskd. 2017;161:D1540.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"1059_CR2","unstructured":"VeiligheidNL. Traumatisch Hersenletsel, ongevalscijfers. 2013. Available from: https:\/\/www.zorgvoorbeter.nl\/docs\/PVZ\/vindplaats\/Dementie\/traumatisch-hersenletsel-factsheet-veiligheid-nl.pdf. Accessed 30 Aug 2022."},{"issue":"5","key":"1059_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S1474-4422(15)00002-2","volume":"14","author":"HS Levin","year":"2015","unstructured":"Levin HS, Diaz-Arrastia RR. Diagnosis, prognosis, and clinical management of mild traumatic brain injury. Lancet Neurol. 2015;14(5):506\u201317.","journal-title":"Lancet Neurol"},{"issue":"3 Suppl","key":"1059_CR4","doi-asserted-by":"publisher","first-page":"S278","DOI":"10.1016\/j.apmr.2013.08.295","volume":"95","author":"JD Cassidy","year":"2014","unstructured":"Cassidy JD, Boyle E, Carroll LJ. Population-based, inception cohort study of the incidence, course, and prognosis of mild traumatic brain injury after motor vehicle collisions. Arch Phys Med Rehabil. 2014;95(3 Suppl):S278\u201385.","journal-title":"Arch Phys Med Rehabil"},{"issue":"12","key":"1059_CR5","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jalz.2017.04.010","volume":"13","author":"AM Tolppanen","year":"2017","unstructured":"Tolppanen AM, Taipale H, Hartikainen S. Head or brain injuries and Alzheimer\u2019s disease: a nested case-control register study. Alzheimers Dement. 2017;13(12):1371\u20139.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1059_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S2215-0366(18)30065-8","volume":"5","author":"JR Fann","year":"2018","unstructured":"Fann JR, Ribe AR, Pedersen HS, Fenger-Gr\u00f8n M, Christensen J, Benros ME, et al. Long-term risk of dementia among people with traumatic brain injury in Denmark: a population-based observational cohort study. Lancet Psychiatry. 2018;5(5):424\u201331.","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"1059_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ana.24396","volume":"77","author":"RC Gardner","year":"2015","unstructured":"Gardner RC, Burke JF, Nettiksimmons J, Goldman S, Tanner CM, Yaffe K. Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol. 2015;77(6):987\u201395.","journal-title":"Ann Neurol"},{"issue":"11","key":"1059_CR8","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1136\/jnnp.74.11.1574","volume":"74","author":"SM Rosso","year":"2003","unstructured":"Rosso SM, Landweer EJ, Houterman M, Donker Kaat L, van Duijn CM, van Swieten JC. Medical and environmental risk factors for sporadic frontotemporal dementia: a retrospective case-control study. J Neurol Neurosurg Psychiatry. 2003;74(11):1574\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3-4","key":"1059_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000369787","volume":"39","author":"MB Deutsch","year":"2015","unstructured":"Deutsch MB, Mendez MF, Teng E. Interactions between traumatic brain injury and frontotemporal degeneration. Dement Geriatr Cogn Disord. 2015;39(3-4):143\u201353.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1-2","key":"1059_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/21678421.2017.1386687","volume":"19","author":"E Pupillo","year":"2018","unstructured":"Pupillo E, Poloni M, Bianchi E, Giussani G, Logroscino G, Zoccolella S, et al. Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(1-2):118\u201325.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"19","key":"1059_CR11","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1212\/WNL.0b013e31826daf50","volume":"79","author":"EJ Lehman","year":"2012","unstructured":"Lehman EJ, Hein MJ, Baron SL, Gersic CM. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79(19):1970\u20134.","journal-title":"Neurology"},{"issue":"19","key":"1059_CR12","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa1908483","volume":"381","author":"DF Mackay","year":"2019","unstructured":"Mackay DF, Russell ER, Stewart K, MacLean JA, Pell JP, Stewart W. Neurodegenerative disease mortality among former professional soccer players. N Engl J Med. 2019;381(19):1801\u20138.","journal-title":"N Engl J Med"},{"issue":"15","key":"1059_CR13","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1001\/jama.1928.02700150029009","volume":"91","author":"HS Martland","year":"1928","unstructured":"Martland HS. Punch drunk. J Am Med Assoc. 1928;91(15):1103\u20137.","journal-title":"J Am Med Assoc"},{"issue":"7","key":"1059_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/NEN.0b013e3181a9d503","volume":"68","author":"AC McKee","year":"2009","unstructured":"McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol. 2009;68(7):709\u201335.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 1","key":"1059_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/brain\/aws307","volume":"136","author":"AC McKee","year":"2013","unstructured":"McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136(Pt 1):43\u201364.","journal-title":"Brain"},{"issue":"134","key":"1059_CR16","doi-asserted-by":"publisher","first-page":"134ra160","DOI":"10.1126\/scitranslmed.3003716","volume":"4","author":"LE Goldstein","year":"2012","unstructured":"Goldstein LE, Fisher AM, Tagge CA, Zhang XL, Velisek L, Sullivan JA, et al. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med. 2012;4(134):134ra160.","journal-title":"Sci Transl Med"},{"issue":"13","key":"1059_CR17","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1212\/WNL.0b013e3182a55f7f","volume":"81","author":"RA Stern","year":"2013","unstructured":"Stern RA, Daneshvar DH, Baugh CM, Seichepine DR, Montenigro PH, Riley DO, et al. Clinical presentation of chronic traumatic encephalopathy. Neurology. 2013;81(13):1122\u20139.","journal-title":"Neurology"},{"issue":"18","key":"1059_CR18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1212\/WNL.0000000000011850","volume":"96","author":"DI Katz","year":"2021","unstructured":"Katz DI, Bernick C, Dodick DW, Mez J, Mariani ML, Adler CH, et al. National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome. Neurology. 2021;96(18):848\u201363.","journal-title":"Neurology"},{"issue":"3","key":"1059_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/1354750X.2020.1735521","volume":"25","author":"MI Hiskens","year":"2020","unstructured":"Hiskens MI, Schneiders AG, Angoa-P\u00e9rez M, Vella RK, Fenning AS. Blood biomarkers for assessment of mild traumatic brain injury and chronic traumatic encephalopathy. Biomarkers. 2020;25(3):213\u201327.","journal-title":"Biomarkers"},{"key":"1059_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fnins.2015.00334","volume":"9","author":"M Sundman","year":"2015","unstructured":"Sundman M, Doraiswamy PM, Morey RA. Neuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTE. Front Neurosci. 2015;9:334.","journal-title":"Front Neurosci"},{"issue":"22","key":"1059_CR21","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1089\/neu.2014.3822","volume":"32","author":"JM Stamm","year":"2015","unstructured":"Stamm JM, Koerte IK, Muehlmann M, Pasternak O, Bourlas AP, Baugh CM, et al. Age at first exposure to football is associated with altered corpus callosum white matter microstructure in former professional football players. J Neurotrauma. 2015;32(22):1768\u201376.","journal-title":"J Neurotrauma"},{"issue":"3","key":"1059_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s11682-015-9442-0","volume":"10","author":"IK Koerte","year":"2016","unstructured":"Koerte IK, Mayinger M, Muehlmann M, Kaufmann D, Lin AP, Steffinger D, et al. Cortical thinning in former professional soccer players. Brain Imaging Behav. 2016;10(3):792\u20138.","journal-title":"Brain Imaging Behav"},{"issue":"4","key":"1059_CR23","doi-asserted-by":"publisher","first-page":"e94734","DOI":"10.1371\/journal.pone.0094734","volume":"9","author":"JJ Bazarian","year":"2014","unstructured":"Bazarian JJ, Zhu T, Zhong J, Janigro D, Rozen E, Roberts A, et al. Persistent, long-term cerebral white matter changes after sports-related repetitive head impacts. PLoS One. 2014;9(4):e94734.","journal-title":"PLoS One"},{"issue":"7","key":"1059_CR24","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00415-016-8141-0","volume":"263","author":"N Multani","year":"2016","unstructured":"Multani N, Goswami R, Khodadadi M, Ebraheem A, Davis KD, Tator CH, et al. The association between white-matter tract abnormalities, and neuropsychiatric and cognitive symptoms in retired professional football players with multiple concussions. J Neurol. 2016;263(7):1332\u201341.","journal-title":"J Neurol"},{"issue":"18","key":"1059_CR25","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1056\/NEJMoa1900757","volume":"380","author":"RA Stern","year":"2019","unstructured":"Stern RA, Adler CH, Chen K, Navitsky M, Luo J, Dodick DW, et al. Tau positron-emission tomography in former national football league players. N Engl J Med. 2019;380(18):1716\u201325.","journal-title":"N Engl J Med"},{"key":"1059_CR26","doi-asserted-by":"publisher","first-page":"102025","DOI":"10.1016\/j.nicl.2019.102025","volume":"24","author":"OH Lesman-Segev","year":"2019","unstructured":"Lesman-Segev OH, La Joie R, Stephens ML, Sonni I, Tsai R, Bourakova V, et al. Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy. NeuroImage Clinical. 2019;24:102025.","journal-title":"NeuroImage Clinical"},{"key":"1059_CR27","doi-asserted-by":"publisher","first-page":"117611","DOI":"10.1016\/j.neuroimage.2020.117611","volume":"227","author":"KS Chan","year":"2021","unstructured":"Chan KS, Marques JP. SEPIA-Susceptibility mapping pipeline tool for phase images. NeuroImage. 2021;227:117611.","journal-title":"NeuroImage"},{"key":"1059_CR28","doi-asserted-by":"crossref","unstructured":"Verberk IMW, Misdorp EO, Koelewijn J, Ball AJ, Blennow K, Dage JL, et al. Characterization of pre-analytical sample handling effects on a panel of Alzheimer\u2019s disease\u2013related blood-based biomarkers: results from the Standardization of Alzheimer\u2019s Blood Biomarkers (SABB) working group. Alzheimers Dement. 2022;18(8):1484\u201397.","DOI":"10.1002\/alz.12510"},{"key":"1059_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.dadm.2017.04.007","volume":"8","author":"S Engelborghs","year":"2017","unstructured":"Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M, et al. Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst). 2017;8:111\u201326.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"22","key":"1059_CR30","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73(22):1914\u201322.","journal-title":"Neurology"},{"issue":"5","key":"1059_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00702-006-0601-8","volume":"114","author":"A Schmitt","year":"2007","unstructured":"Schmitt A, Bauer M, Heinsen H, Feiden W, Falkai P, Alafuzoff I, et al. How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II. J Neural Transm (Vienna). 2007;114(5):527\u201337.","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"1059_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 2012;123(1):1\u201311.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1059_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13195-021-00872-x","volume":"13","author":"ML Alosco","year":"2021","unstructured":"Alosco ML, Mariani ML, Adler CH, Balcer LJ, Bernick C, Au R, et al. Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project. Alzheimers Res Ther. 2021;13(1):136.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"1059_CR34","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1007\/s00415-021-10403-1","volume":"268","author":"G Seghezzo","year":"2021","unstructured":"Seghezzo G, Van Hoecke Y, James L, Davoren D, Williamson E, Pearce N, et al. Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite (PACC) score via videoconferencing. J Neurol. 2021;268(6):2228\u201337.","journal-title":"J Neurol"},{"issue":"12","key":"1059_CR35","doi-asserted-by":"publisher","first-page":"e017990","DOI":"10.1136\/bmjopen-2017-017990","volume":"7","author":"V Gallo","year":"2017","unstructured":"Gallo V, McElvenny D, Hobbs C, Davoren D, Morris H, Crutch S, et al. BRain health and healthy AgeINg in retired rugby union players, the BRAIN Study: study protocol for an observational study in the UK. BMJ Open. 2017;7(12):e017990.","journal-title":"BMJ Open"},{"issue":"1","key":"1059_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/JAD-132306","volume":"41","author":"WM van der Flier","year":"2014","unstructured":"van der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, et al. Optimizing patient care and research: the Amsterdam Dementia Cohort. J Alzheimers Dis. 2014;41(1):313\u201327.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1059_CR37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/jamaneurol.2019.4509","volume":"77","author":"WG Mantyh","year":"2020","unstructured":"Mantyh WG, Spina S, Lee A, Iaccarino L, Soleimani-Meigooni D, Tsoy E, et al. Tau positron emission tomographic findings in a former US football player with pathologically confirmed chronic traumatic encephalopathy. JAMA Neurol. 2020;77(4):517\u201321.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1059_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jmri.26162","volume":"49","author":"R Ruprecht","year":"2019","unstructured":"Ruprecht R, Scheurer E, Lenz C. Systematic review on the characterization of chronic traumatic encephalopathy by MRI and MRS. J Magn Reson Imaging. 2019;49(1):212\u201328.","journal-title":"J Magn Reson Imaging"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01059-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T01:02:47Z","timestamp":1662080567000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01059-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01059-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All research conducted by NEwTON is in accordance with the WMA Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects 2013 and has been reviewed by the Medical Ethics Committee from the Amsterdam UMC. Approval was obtained at June 1, 2021. Before participation, all subjects signed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DKC is part-time employee of Brain Research Center Amsterdam. RO is an Associate Editor of Alzheimer\u2019s Research & Therapy. FB is supported by the NIHR biomedical research center at UCLH. CET is a member of the Innogenetics International Advisory Boards of Fujirebio\/Innogenetics and Roche. She has received research reagents from ADxNeurosciences and Euroimmun and has a collaboration contract with ADx Neurosciences and with Quanterix. She has performed contract research or received grants from AC Immune, AxonNeurosciences, Biogen, Boehringer, Brainstorm Therapeutics, Celgene, CogRx, EIP Pharma, Esai, Fujirebio, Janssen prevention center, PeopleBio, Probiodrug, Roche, Toyama, and Vivoryon. Research of CET is supported by the European Commission (Marie Curie International Training Network, JPND), Health Holland, the Dutch Research Council (ZonMW), The Weston Brain Institute, Alzheimer Netherlands, Alzheimer Association. She is one of the Associate Editors of Alzheimer Research & Therapy. PS has received consultancy fees (paid to the institutions) from AC Immune, Alkermes, Alnylam, Alzheon, Anavex, Axoltis, Brainstorm Cell, Cortexyme, Denali, EIP, ImmunoBrain Checkpoint, GemVax, Genentech, Green Valley, Novartis, Novo Nordisk, PeopleBio, Renew LLC, and Roche. He received payment or honoraria from Nutricia. He is PI of studies with AC Immune, CogRx, FUJI-film\/Toyama, IONIS, UCB, and Vivoryon. He is a part-time employee of Life Sciences Partners Amsterdam, and he serves on the board of New Amsterdam Pharma. He is chief-in-editor of Alzheimer Research & Therapy. EGBV has received consultancy fees (paid to the institution) from Biogen, Brainstorm Therapeutics, ImmunoBrain Checkpoint, New Amsterdam Pharma, ReMynd and Treeway, Vivoryon, Vigil Neuroscience. He is PI of studies with ACImmune, CogRx, Green Valley, IONIS, Janssen, Roche, Rodin Therapeutics, Sanofi, UCB, and Vivoryon.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}